Researchers at the Medical University of South Carolina published a study in Cell Reports in March 2026 that is generating significant attention in the health and nutrition community.
The finding challenges one of the most widely held assumptions in nutritional medicine, that omega-3 fatty acids in fish oil supplements are uniformly protective for the brain.
The study found that EPA, one of the two main omega-3 fatty acids in fish oil, may interfere with the brain’s ability to repair itself after injury. DHA, the other main omega-3, did not show this effect.
The difference between those two molecules, two components of the same supplement that most people take as a single capsule without distinguishing between them, is the central finding of the paper and the reason it is generating conversation.
“Fish oil supplements are everywhere, and people take them for a range of reasons, often without a clear understanding of their long-term effects,” said lead researcher Onder Albayram, a neuroscientist and associate professor at MUSC. “But in terms of neuroscience, we still don’t know whether the brain has resilience or resistance to this supplement. That’s why ours is the first such study in the field.”
The Two Omega-3s You Need To Know About
Most people who take fish oil supplements think of them as delivering one thing. Omega-3 fatty acids.
The actual picture is more specific. Fish oil contains two distinct omega-3 fatty acids that behave very differently in the body and in the brain.
DHA, docosahexaenoic acid, is the omega-3 that most of the brain’s positive reputation for fish oil is built on. DHA is a structural component of neuronal cell membranes.
When you consume DHA, the brain incorporates it into the physical structure of brain cells themselves, where it stays and contributes to normal brain function.
The evidence that DHA supports brain health across a lifetime is substantial and consistent.
EPA, eicosapentaenoic acid, is different. It is less fixed in neuronal membranes. It moves more freely through the body and can enter metabolic processes related to how cells use energy.
Under normal circumstances in a healthy brain, this difference is not particularly alarming.
Under the specific circumstances this study examined, repeated mild traumatic brain injuries in a brain that is trying to repair itself, the difference became significant.
What The Study Actually Found
The research used three layers of evidence to build its case. The first was mice.
Researchers fed mice diets containing EPA and then subjected them to repeated mild traumatic brain injuries, the kind of low-level impacts that might occur in contact sports, certain military activities, or accidents.
The mice fed EPA diets performed worse on spatial memory and learning tasks after the injuries than they would have been expected to.
Analysis of their brain tissue showed that EPA had accumulated specifically in the injured portions of the brain and had triggered changes in the neurovascular unit, the system that regulates blood flow to brain tissue and plays a central role in the repair process after injury.
The second layer was human cells. Researchers isolated human-derived brain microvascular endothelial cells, the cells that make up the blood-brain barrier, the protective interface between the brain and the bloodstream.
They exposed these cells to EPA and to DHA separately and pushed them to perform repair functions. EPA, but not DHA, reduced the cells’ ability to form new networks, slowed the speed at which they closed wounds, and weakened the tight contacts between neighboring cells that are essential to maintaining the integrity of the blood-brain barrier.
DHA left these repair functions intact. EPA impaired them.
The third layer was human tissue from people who had died with confirmed chronic traumatic encephalopathy, CTE, the degenerative brain disease associated with repeated head injuries.
Analysis of postmortem brain tissue from these individuals showed patterns of metabolic disruption and blood vessel damage that were consistent with what the researchers had seen in mice and human cell experiments.
The mechanism underlying all three findings is what the researchers call a “context-dependent metabolic vulnerability.”
In plain terms, EPA reprograms how brain blood vessel cells use energy, shifting their metabolic priorities in ways that leave less capacity for repair.
This reprogramming does not appear to happen in healthy, uninjured brains in normal circumstances.
It appears specifically in brains that are in repair mode after injury, where the cells are already under stress and need all available resources to rebuild.
EPA, in the researchers’ framing, does not poison the brain outright.
It nudges injured vessels away from the work of rebuilding. The distinction matters because it means the risk is specific and contextual, not universal.
The CTE Implication
The connection to CTE is the dimension of this study with the most immediate real-world relevance, particularly for athletes, military personnel, and others who experience repeated head impacts.
CTE is a progressive neurodegenerative disease caused by repeated traumatic brain injuries, including the small, subconcussive impacts that occur in contact sports on every play, not just the dramatic concussions that get players sent off the field.
It has been found in former NFL players, former military veterans, and others with histories of repeated head trauma.
The tau protein buildup that the researchers found in the mouse brains, a hallmark of CTE and a marker of neurodegeneration, is one of the most significant specific findings in the paper.
The researchers speculate that people with repeated mild concussions who take fish oil supplements containing EPA may be impairing their brain’s ability to recover from those small injuries, potentially increasing their risk of CTE over time.
An athlete who takes fish oil as a neuroprotective supplement, on the reasonable assumption that omega-3s are good for the brain, may be doing something counterproductive if that supplement contains substantial EPA.
The word “speculate” matters here. The researchers are careful to say that the human CTE tissue analysis is observational, it identifies patterns consistent with their hypothesis but cannot prove what caused those patterns.
They also acknowledge that they cannot control for every variable in a real human life including overall diet, general health and lifestyle. These findings are a starting point for a line of inquiry, not a conclusion.
What To Ignore About This News
The researchers are explicit that this finding does not mean fish oil is bad for you. Onur Eskiocak of Cold Spring Harbor Laboratory, one of the study’s co-researchers, said it plainly:
“This idea of fish oil being a one-size-fits-all benefit doesn’t work once you start investigating interactions. But that doesn’t mean it’s bad for you.”
The harmful effect of EPA appears only in the context of repeated brain injury and active repair mode.
In a healthy person with no history of repeated head trauma who is not in any kind of neurological repair state, the mechanism identified in this study does not appear to apply.
The extensive evidence for DHA’s benefits, its role in brain cell membrane structure, its contributions to cognitive function over a lifetime, is not challenged by this paper. DHA comes through this research with its reputation intact.
What the study does challenge is the idea that all omega-3 fatty acids in a fish oil supplement behave the same way and that a fish oil capsule is a generic brain-health intervention that works equally well for everyone in every circumstance. It does not.
EPA and DHA are different molecules with different behaviors in the brain, and the assumption that they are interchangeable components of the same benefit may be wrong in specific and important contexts.
What To Look For On Your Supplement Label
Most standard fish oil supplements contain both EPA and DHA, and labels typically list both amounts separately.
Common ratios are roughly 180 mg EPA and 120 mg DHA per capsule, though this varies significantly across brands and formulations.
Some supplements are formulated to maximize DHA content specifically, products marketed for cognitive health, infant brain development, or aging-related brain protection often emphasize DHA over EPA.
Others are formulated with higher EPA content, particularly products marketed for cardiovascular health, anti-inflammatory purposes, or mood support.
For people without repeated head trauma histories the current research does not provide grounds to stop taking fish oil.
For athletes in contact sports, military personnel in roles with repeated blast exposure, or anyone with a documented history of repeated concussions or mild traumatic brain injuries, this research provides the first scientific basis for a more careful look at which omega-3 supplement they are taking and what the EPA-to-DHA ratio looks like.
Albayram’s team is planning next steps that include tracking how EPA moves through the body, defining the transport mechanisms that control how it reaches the brain, and potentially designing clinical trials to test these findings in living human subjects.
“This paper is a starting point, but it is an important one,” Albayram said. “It opens a new conversation about precision nutrition in neuroscience, and it gives the field a framework to ask better, more testable questions.”
The answer to those questions is still being found. What exists right now is the clearest evidence yet that two molecules in the same supplement capsule behave very differently in the brain, and that in the specific context of repeated injury and repair, that difference may matter considerably.
